[DOI] [PMC free article] [PubMed] [Google Scholar] 51.Dai S., Zheng Y., Wang Y., Chen Z
Nakajima A, Negishi N, Tsurui H, Kadowaki-Ohtsuji N, Maeda K, Nanno M et al
GLP-1 Receptor Agonists In patients with HFpEF and comorbid obesity or type 2 diabetes mellitus, semaglutide has been incorporated into the 2025 JCS/JHFS heart failure guidelines with a Class IIa recommendation (Level of Evidence B), reflecting moderate-quality evidence supporting improvement in symptoms and functional status
Gadhave et al performed nose-to-brain delivery of teriflunomide using an NLC with an ion-sensitive ISG formulation for glioma treatment
Directing the stream down the inside vial wall allows the powder to hydrate gradually through diffusion rather than direct impact, preserving peptide structure and maintaining full potency